FDA Clears DreaMed MODI: First CGM-Driven Insulin Dose Optimization App for Type 2 Injection Therapy
DreaMed Diabetes receives FDA 510(k) clearance for MODI, the first mobile app delivering autonomous insulin dose adjustments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results